Circadian variations in central corneal thickness and intraocular pressure in patients with glaucoma

British Journal of Ophthalmology

Volumn 90, Issue 1, 2006, Pages 24-28

  Fogagnolo, P ^a   Rossetti, L ^a   Mazzolani, F ^a   Orzalesi, Nicola ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b Ospedale San Paolo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; TIMOLOL MALEATE;

ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CORNEA THICKNESS; EVALUATION; FEMALE; GLAUCOMA; HOSPITALIZATION; HUMAN; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; SITTING; SUPINE POSITION; TONOMETER;

AGED; AGED, 80 AND OVER; CIRCADIAN RHYTHM; CORNEA; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; POSTURE; TONOMETRY, OCULAR;

EID: 29744445332     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.079285     Document Type: Article

References (48)

1. Konstas AG, Katsimbris JM, Lallos N, et al. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients. Ophthalmology 2005;112:262-6.
2. Konstas AG, Karabatsas CH, Lallos N, et al. 24-Hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects. Ophthalmology 2005;112:603-8.
3. Liu JH, Kripke DF, Weinreb RN. Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure. Am J Ophthalmol 2004;138:389-95.
4. Orzalesi N, Rossetti L, Invernizzi T, et al. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci 2000;41:2566-73.
5. Orzalesi N, Rossetti L, Bottoli A, et al. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Arch Ophthalmol 2003;121:453-7.
6. Asrani S, Zeimer R, Wilensky J, et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 2000;9:134-42.
7. Bengtsson B, Heijl A. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Graefes Arch Clin Exp Ophthalmol 2005;243:513-8.
8. Mosaed S, Liu JH, Weinreb RN. Correlation between office and peak nocturnal intraocular pressures in healthy subjects and glaucoma patients. Am J Ophthalmol 2005;139:320-4.
9. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Advanced Glaucoma Intervention Study. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 2004;111:1627-35.
10. Azuara-Blanco A, Bhojani TK, Sarhan AR, et al. Tono-Pen determination of IOP in patients with band keratopathy or glued cornea. Br J Ophthalmol 1998;82:634-6.
11. Drance SM. The coefficient of scleral rigidity in normal and glaucomatous eyes. Arch Ophthalmol 1960;63:668-74.
12. Goldmann H, Schmidt T. Uber applanationstonometrie. Ophthalmologica 1957;134:221-42.
13. Holladay JT, Allison ME, Prager TC. Goldmann applanation tonometry in patients with regular corneal astigmatism. Am J Ophthalmol 1983;96:90-3.
14. Kaufman HE. Pressure measurement: which tonometer. Invest Ophthalmol Vis Sci 1972;11:80-5.
15. Ehlers N, Bramsen T, Sperling S. Applanation tonometry and central corneal thickness. Acta Ophthalmol 1975;53:34-43.
16. Mardelli PG, Piebenga LW, Whitacre MM, et al. The effect of excimer laser photorefractive keratectomy on intraocular pressure measurements using Goldmann applanation tonometer. Surv Ophthalmol 1997;104:945-9.
17. Rashad KM, Bahnassy AA. Changes in intraocular pressure after laser in situ keratomileusis. J Refract Surg 2001;17:420-7.
18. Argus WA. Ocular hypertension and central corneal thickness. Ophthalmology 1995;102:1810-12.
19. Copt RP, Thomas R, Mermoud A. Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Opthalmol 1999;117:104-5.
20. Herman DC, Hodge DO, Bourne WM. Increased corneal thickness in patients with ocular hypertension. Arch Ophthalmol 2001;119:334-6.
21. Herndon LW, Choudhri SA, Cox T, et al. Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol 1997;115:1137-41.
22. Johnson M, Kass MA, Moses RA, et al. Increased corneal thickness simulating elevated intraocular pressure. Arch Ophthalmol 1977;96:664-5.
23. Shah S, Chatterjee A, Mathai M, et al. Relationship between corneal thickness and measured intraocular pressure in a general ophthalmology clinic. Ophthalmology 1999;106:2154-60.
24. Ehlers N, Hansen FK. Central corneal thickness in low-tension glaucoma. Acta Ophthalmol (Copenh) 1974;52:740-6.
25. Morad Y, Sharon E, Hefetz L, et al. Corneal thickness and curvature in normal-tension glaucoma. Am J Ophthalmol 1998;125:164-8.
26. Tanaka GH. Corneal pachymetry: a prerequisite for applanation tonometry? Arch Ophthalmol 1998;116:544-5.
27. Bron AM, Creuzot-Garcher C, Goudeau-Boutillon S, et al. Falsely elevated intraocular pressure due to increased central corneal thickness. Graefes Arch Clin Exp Ophthalmol 1999;237:220-4.
28. Doughty MJ, Zamzn ML. Human corneal thickness and its impact on intraocular pressure measures. A review and meta-analysis approach. Surv Ophthalmol 2000;44:367-408.
29. Whitacre MM, Stein RA, Hassanein K. The effect of corneal thickness on applanation tonometry. Am J Ophthalmol 1993;115:592-6.
30. McLaren JW, Nau CB, Erie JC, et al. Corneal thickness measurement by confocal microscopy, ultrasound, and scanning slit methods. Am J Ophthalmol 2004;137:1011-20.
31. Miglior S, Albe E, Guareschi M, et al. Intraobserver and interobserver reproducibility in the evaluation of ultrasonic pachymetry measurements of central corneal thickness. Br J Ophthalmol 2004;88:174-7.
32. Li HG, Petroll WM, Moller-Pedersen T, et al. Epithelial and corneal thickness measurements by in vivo confocal microscopy through focusing (CMTF). Curr Eye Res 1997;16:214-21.
33. Feng Y, Varikooty J, Simpson TL. Diurnal variation of corneal and corneal epithelial thickness measured using optical coherence tomography. Cornea 2001;20:480-3.
34. Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures. A review and meta-analysis approach. Surv Ophthalmol 2000;44:367-408.
35. Shah S, Spedding C, Bhojwani R, et al. Assessment of the diurnal variation in central corneal thickness and intraocular pressure for patients with suspected glaucoma. Ophthalmology 2000;107:1191-3.
36. Harper CL, Boulton ME, Bennett D, et al. Diurnal variations in human corneal thickness. Br J Ophthalmol 1996;80:1068-72.
37. Damji KF, Muni RH, Munger RM. Influence of corneal variables on accuracy of intraocular pressure measurement. J Glaucoma 2003;12:69-80.
38. Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991.
39. Sudesh S, Moseley MJ, Thompson JR. Accuracy of Goldmann tonometry in clinical practice. Acta Ophthalmol (Copenh) 1993;71:185-8.
40. Liu JH, Zhang X, Kripke DF, et al. Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci 2003;44:1586-90.
41. Liu JH, Kripke DF, Hoffman RE, et al. Nocturnal elevation of intraocular pressure in young adults. Invest Ophthalmol Vis Sci 1998;39:2707-12.
42. Herndon LW, Weizer JS, Stinnett SS. Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol 2004;122:17-21.
43. Klyce SD. Stromal lactate accumulation can account for corneal oedema osmotically following epithelial hypoxia in the rabbit. J Physiol 1981;321:49-64.
44. Weinreb RN, Lu A, Beeson C. Maternal corneal thickness during pregnancy. Am J Ophthalmol 1988;105:258-60.
45. Feldman F, Bain J, Matuk AR. Daily assessment of ocular and hormonal variables throughout the menstrual cycle. Arch Ophthalmol 1978;96:1835-8.
46. Soni PS. Effects of oral contraceptive steroids on the thickness of human cornea. Am J Optom Physiol Opt 1980;57:825-34.
47. Nielsen CB, Nielsen PJ. Effect of alpha- and beta-receptor active drugs on corneal thickness. Acta Ophthalmol (Copenh) 1985;63:351-4.
48. Lass JH, Eriksson GL, Osterling L, et al. Latanoprost Corneal Effects Study Group. Comparison of the corneal effects of latanoprost, fixed combination latanoprost-timolol, and timolol: a double-masked, randomized, one-year study Ophthalmology 2001;108:264-71.